Skip to main content
Premium Trial:

Request an Annual Quote

We'll Return to Our Regularly Scheduled Programming in a Moment

Full disclosure: this is a blatantly self-promotional post. Our sister publication, Genome Technology magazine, features a cover story on the rise of open access this month -- it's meant to distill the key points of debate about open access and to serve as a primer for scientists who may have heard of OA but don't really know what all the hoopla's about. In the spirit of open access, the full issue is available through a Creative Commons license. You can check out the November issue here -- no subscription is required to read it.

Many thanks to Jonathan Eisen, Michael Eisen, and Peter Suber for mentioning the open access story on their blogs.


The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.